How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?: A Redefinition of Evidence-Based Medicine

被引：145
|
作者：
McMurray, John J. V. [1 ]
Packer, Milton [2 ]
机构：
[1] Univ Glasgow, British Heart Fdn Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland
[2] Baylor Univ, Med Ctr, Dallas, TX USA
来源：
CIRCULATION | 2021年 / 143卷 / 09期
关键词：
adrenergic beta-antagonists; aldosterone; angiotensin converting enzyme inhibitors; heart failure; neprilysin; receptors; mineralocorticoid; sodium-glucose transport proteins; MORTALITY;
D O I：
10.1161/CIRCULATIONAHA.120.052926
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：875 / 877
页数：3
相关论文
共 50 条
  • [41] Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments
    Naegele, Matthias
    Flammer, Andreas J.
    Enseleit, Frank
    Ruschitzka, Frank
    SWISS MEDICAL WEEKLY, 2016, 146 : w14295
  • [42] Evidence-Based Process Performance Measures and Clinical Outcomes in Patients With Incident Heart Failure With Reduced Ejection Fraction: A Danish Nationwide Cohort Study
    Schjodt, Inge
    Johnsen, Soren P.
    Stromberg, Anna
    DeVore, Adam D.
    Valentin, Jan B.
    Logstrup, Brian B.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2022, 15 (04): : 281 - 293
  • [43] Optimization of Drug Therapy for Heart Failure With Reduced Ejection Fraction Based on Gender
    Iacoviello, Massimo
    Pugliese, Rosanna
    Correale, Michele
    Brunetti, Natale Daniele
    CURRENT HEART FAILURE REPORTS, 2022, 19 (06) : 467 - 475
  • [44] Optimization of Drug Therapy for Heart Failure With Reduced Ejection Fraction Based on Gender
    Massimo Iacoviello
    Rosanna Pugliese
    Michele Correale
    Natale Daniele Brunetti
    Current Heart Failure Reports, 2022, 19 : 467 - 475
  • [45] Should vericiguat be initiated in geriatric inpatients with heart failure with reduced ejection fraction and a worsening heart failure event prior to discharge?
    Hias, Julie
    Hellemans, Laura
    Walgraeve, Karolien
    Tournoy, Jos
    Vandenbriele, Christophe
    Van Aelst, Lucas
    Van der Linden, Lorenz Roger
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2023, 30 (06) : 367 - 369
  • [46] Developing evidence-based treatments for the management of pediatric heart failure
    Shaddy, Robert E.
    PROGRESS IN PEDIATRIC CARDIOLOGY, 2015, 39 (01) : 53 - 55
  • [47] Heart failure with reduced ejection fraction and the intersection of cardio-renal-metabolic medicine #CaReMe
    Marx, Nikolaus
    Cheng, Alice Y. Y.
    Agarwal, Rajiv
    Greene, Stephen J.
    Abuhantash, Hadi
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 : L29 - L37
  • [48] Heart failure with reduced ejection fraction foundational therapy: should we follow the 2021 European Society of Cardiology Heart Failure Guidelines and forget the previous therapeutic algorithm?
    Sara Couto Pereira, S.
    Agostinho, J. R.
    Silverio Antonio, P.
    Brito, J.
    Alves Da Silva, P.
    Martins, A. M.
    Garcia, B.
    Simoes De Oliveira, C.
    Santos, R.
    Rigueira, J.
    Lousada, N.
    Silva, D.
    Pinto, F. J.
    Brito, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 129 - 129
  • [49] The evolution of heart failure with reduced ejection fraction pharmacotherapy: What do we have and where are we going?
    Selim, Ahmed
    Zolty, Ronald
    Chatzizisis, Yiannis S.
    PHARMACOLOGY & THERAPEUTICS, 2017, 178 : 67 - 82
  • [50] How Should Physicians Assess Myocardial Contraction? Redefining Heart Failure With a Preserved Ejection Fraction
    Maurer, Mathew S.
    Packer, Milton
    JACC-CARDIOVASCULAR IMAGING, 2020, 13 (03) : 873 - 878
12345